
Ed Haislmaier
Ed Haislmaier is an expert in healthcare policy and markets at The Heritage Foundation, a conservative think tank. He focuses on the dynamics of healthcare pricing and regulation, offering insights into how government policies can affect the pharmaceutical market. Recently, he commented on the Trump administration's initiatives to lower drug prices, suggesting that the agreements with pharmaceutical companies might mitigate some of the negative impacts often associated with price controls.
Not in the pool (under ¢1).
Recent news mentions
Ed Haislmaier is a senior research fellow in Heritage's DeVos Center for Human Flourishing.
Welfare fraud reveals systemic flaws in US programs costing billionsEd Haislmaier, an expert in healthcare policy and markets at The Heritage Foundation, discussed the recent agreements involving companies trading lower prices for benefits.
Trump rolls out drug price deals but economists warn future cures could suffer





